PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 321 results · Data & Publications  · Clear
🔒 Subscribers only
AUTH/3003/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Clinuvel UK
A complaint was brought by the PMCPA Director against Clinuvel UK.The subject matter related to clinical trial disclosure for Scenesse.Complaint received: 20 December 2017.
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/3002/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Octapharma
The PMCPA Director raised a case against Octapharma concerning clinical trial disclosure relating to Nuwiq.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/3000/12/17
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
A case was brought by the PMCPA Director against Roche.The subject matter related to clinical trial disclosure for Gazyvaro.The case was assessed under the 2016 ABPI Code of Practice.
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2999/12/17
Data & Publications Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Otsuka
A case was brought by the PMCPA Director against Otsuka.The subject matter related to clinical trial disclosure for Deltyba.Complaint received: 20 December 2017.Applicable Code year: 2016.Case comp…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2985/10/17
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Sun Pharma
A lead cancer pharmacist complained about an email promotion for Sun Pharma’s gemcitabine 10mg/ml ready-to-administer (RTA) infusion bags (ref SUNUK031), promoted as “The Only Licensed Ready-To…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2998/12/17
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Lilly
A matter was raised by the PMCPA Director concerning clinical trial disclosure relating to Cyramza.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2966/8/17
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Takeda
A complaint was made by a consultant against Takeda.The complaint related to the promotion of vedolizumab.The PMCPA considered the matter under the ABPI Code of Practice (applicable Code year: 2016).
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2979/9/17
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
PharmaMar
A case was brought by an anonymous, non-contactable complainant against PharmaMar.The case reference is AUTH/2979/9/17.No further factual background was provided in the supplied case text.
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2908/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bayer
A CMRO transparency study (published online 25 Nov 2016) assessed whether results of company-sponsored trials linked to EMA 2013 approvals were disclosed within 12 months and by 31 Jul 2015.The PMC…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2898/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
The PMCPA Director opened a complaint after a CMRO transparency study (published 25 Nov 2016) suggested Roche had not disclosed one evaluable trial result within the required timeframe for Kadcyla …
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2884/10/16
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Intrapharm
A CCG medicines management team member complained about a letter Intrapharm sent to GP practices in the named CCG (ref ccf-222-001), copied to the PMCPA.The letter was headed “New Carbocisteine i…
Clauses: 9.1,9.2
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2858/7/16
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Bayer
A complaint was made by a health professional against Bayer.The allegation was “promotion to the public”.Case reference: AUTH/2858/7/16.Complaint received: 26 July 2016.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2891/11/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas
An ex-employee made a complaint about Astellas.The case topic is listed as “Certification and review of materials”.The PMCPA considered the matter under the ABPI Code process.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2894/11/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Mitsubishi Tanabe
A complaint was brought by the Director against Mitsubishi Tanabe.The subject matter related to clinical trial disclosure for BindRen.The case was completed on the same date it was received.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2895/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Boehringer Ingelheim
A complaint was brought by the Director against Boehringer Ingelheim.The subject matter related to clinical trial disclosure for Giotrif.Complaint received: 06 December 2016.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2896/11/16
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen
A complaint was considered under case AUTH/2896/11/16.The case related to clinical trial disclosure for Invokana.The complainant was the Director (PMCPA).Company: Janssen.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2899/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Aegerion
A matter was raised by the PMCPA Director regarding clinical trial disclosure relating to Lojuxta.The case was considered under the PMCPA complaints process.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2900/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Sanofi
The PMCPA Director raised a complaint against Sanofi concerning clinical trial disclosure relating to Lyxumia and Zaltrap.The matter was considered under case numbers AUTH/2900/11/16 and AUTH/2910/…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2904/11/16
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
A matter was considered by the PMCPA involving the Director and Lundbeck.The case related to clinical trial disclosure for Selincro.Complaint received: 06 December 2016.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2905/11/16
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
A Menarini
A complaint was considered under case number AUTH/2905/11/16.The complainant was the Director (PMCPA).The respondent company was A Menarini.The PMCPA assessed whether the matter fell within the sco…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2907/11/16
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Takeda
A matter was considered by the PMCPA involving the Director and Takeda.The case related to clinical trial disclosure for Vipidia.Complaint received: 06 December 2016.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2909/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Astellas UK
The Director raised a complaint against Astellas UK.The issue related to clinical trial disclosure concerning Xtandi.The case was recorded as completed on the same date it was received.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2855/7/16
Data & Publications Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Boehringer Ingelheim and Lilly
A pharmacist complained about a promotional email (Ref UK/GLA/00177) sent (5 July 2016) to a nurse in an NHS clinical commissioning group (CCG).The email subject line stated: “Biosimilar insulin …
Clauses: 9.1
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2844/5/16
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Amdipharm Mercury
Amdipharm Mercury Company (AMCo) voluntarily admitted that a representative sent an unapproved promotional email about Lutrate (leuprorelin) to a prescribing advisor.The email was discovered during…
Clauses: NONE
2016 🔒 Subscribe
← Prev 1 2 3 4 5 6 7 Next → Page 4 of 14 — 321 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews